Clinical trial
A Phase 2A Randomized, Placebo Controlled Trial of EPI-743 in Children With Rett Syndrome
NCT01822249 is registered in ClinicalTrials.gov with Edison Pharmaceuticals Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2A Randomized, Placebo Controlled Trial of EPI-743 in Children With Rett Syndrome
- Lead sponsor
- Edison Pharmaceuticals Inc
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- January 31, 2014
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.